Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | TLR4 | O00206 | 7/20 | 0.35 |
| ▸ | LY96 | Q9Y6Y9 | 6/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25957853 | 0.88 | MAPK1 (0.47) | PYGBMAPK1NOD2ALDH1A1THRB | |
| SCHEMBL28889012 | 0.88 | MAPK1 (0.47) | PYGBMAPK1NOD2ALDH1A1THRB | |
| SCHEMBL21137905 | 0.88 | MAPK1 (0.47) | PYGBMAPK1NOD2ALDH1A1THRB | |
| SCHEMBL29777467 | 0.88 | MAPK1 (0.47) | PYGBMAPK1NOD2ALDH1A1THRB | |
| Hydrochloric Acid SCHEMBL21058344 | 0.87 | MAPK1 (0.46) | PYGBMAPK1NOD2ALDH1A1THRB | |
| Hydrochloric Acid SCHEMBL30033750 | 0.87 | MAPK1 (0.46) | PYGBMAPK1NOD2ALDH1A1THRB | |
| SCHEMBL21138210 | 0.83 | PYGB (0.52) | PYGBMAPK1KDM4ELMNACYP2D6 | |
| SCHEMBL21137920 | 0.78 | PYGB (0.44) | PYGBMAPK1ALDH1A1THRBTLR4 | |
| SCHEMBL25835418 | 0.78 | PYGB (0.44) | PYGBMAPK1ALDH1A1THRBTLR4 | |
| SCHEMBL6894939 | 0.78 | MAPK1 (0.56) | PYGBMAPK1NOD2ALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210079033-A1 | GLUCOSAMINE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF JOINT DISORDERS | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2021-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210079033-A1 | GLUCOSAMINE DERIVATIVES FOR THE PREVENTION OR TREATMENT OF JOINT DISORDERS | OGT, UGGT1, GLA | PYGB 760/4885MAPK1 887/4885NOD2 691/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.